Last updated on October 2016

A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C


Brief description of study

The purpose of the study is to compare the Pharmacokinetics (PK) of Process E belatacept relative to Process C belatacept in Healthy subjects

Clinical Study Identifier: NCT02564497

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Recruiting sites have contact information. ...

PPD Development
Austin, TX United States
  Connect »